chuminhua2019-10-23 23:33
10/22,Trovagene公$Trovagene(TROV)$ 宣布,其在研PLK1抑制剂onvansertib(PCM-075),与Folfiri,Avastin(bevacizumab)联合,作为二线疗法在治疗携带KRAS基因突变的转移性结直肠癌(CRC)患者的1b/2期临床试验中,取得积极的试验初期数据。在第一批患者的分析中,观察到肿瘤KRAS基因突变负荷水...查看全文
牛唐2019-08-21 14:21
$Ardelyx(ARDX)$ $Trovagene(TROV)$ 放量上涨的runup走势,9月13号,ARDX的药物Ibresla在IBS适应症方面会有审批,9月底前计划公布高磷酸盐血症方面的三期topline data;trov是在8月24日计划公布 Onvansertib 与Zytiga的二期数据$复星医药(SH600196)$查看全文
越炒股越美2019-04-25 14:53
【汇众医疗】4月23日医药股盘点:6支生物制药股势头强劲,上涨幅度均高于15%
$Atossa Genetics(ATOS)$$Trovagene(TROV)$ $Athersys(ATHX)$ 4月23日股市收盘时,6支生物制药公司股票上涨,涨幅均高于15%。而研发乳腺癌药物的Atossa Genetics以3.48美元收盘,上涨22.97%,涨幅最大。研究罕见病药...查看全文
$TrovaGene, Inc.(TROV)$ 8-K - Current report Filed: 2018-02-26 AccNo: 0001193125-18-058657 Size: 129 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$TrovaGene, Inc.(TROV)$ 8-K - Current report Filed: 2018-02-13 AccNo: 0001193125-18-042636 Size: 35 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$TrovaGene, Inc.(TROV)$ 8-K - Current report Filed: 2018-02-12 AccNo: 0001193125-18-039569 Size: 38 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$TrovaGene, Inc.(TROV)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-09 AccNo: 0001104659-18-007913 Size: 87 KB 网页链接
$TrovaGene, Inc.(TROV)$ 8-K - Current report Filed: 2018-02-06 AccNo: 0001193125-18-032742 Size: 34 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$TrovaGene, Inc.(TROV)$ 内部交易: 2018-01-30,CEO,WELCH WILLIAM J ,期权,130000普通股, $0.00
$TrovaGene, Inc.(TROV)$ 内部交易: 2018-01-30,Chief Scientific Officer,Erlander Mark ,期权,90000普通股, $0.00
$TrovaGene, Inc.(TROV)$ 8-K - Current report Filed: 2018-01-24 AccNo: 0001104659-18-003696 Size: 47 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$TrovaGene, Inc.(TROV)$ CORRESP [Cover] - Correspondence Filed: 2017-12-13 AccNo: 0001193125-17-368412 Size: 13 KB 网页链接
$TrovaGene, Inc.(TROV)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-01-09 AccNo: 0001535610-18-000045 Size: 13 KB 网页链接